BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33585818)

  • 1. Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study.
    Habbous S; Forster K; Darling G; Jerzak K; Holloway CMB; Sahgal A; Das S
    Neurooncol Adv; 2021; 3(1):vdaa178. PubMed ID: 33585818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease.
    Erickson AW; Habbous S; Wright F; Lofters AK; Jerzak KJ; Das S
    JAMA Oncol; 2021 Aug; 7(8):1220-1224. PubMed ID: 34081080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
    Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
    J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease.
    Gaebe K; Li AY; Das S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival.
    Erickson AW; Das S
    Front Oncol; 2019; 9():797. PubMed ID: 31508362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review.
    Sherman M; Gaebe K; Li AY; Habbous S; Sahgal A; Raphael MJ; Erickson AW; Das S
    J Neurooncol; 2022 Dec; 160(3):735-742. PubMed ID: 36372832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
    Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
    Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
    Schouten LJ; Rutten J; Huveneers HA; Twijnstra A
    Cancer; 2002 May; 94(10):2698-705. PubMed ID: 12173339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
    Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
    JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases.
    Steindl A; Yadavalli S; Gruber KA; Seiwald M; Gatterbauer B; Dieckmann K; Frischer JM; Klikovits T; Zöchbauer-Müller S; Grisold A; Hoda MAR; Marosi C; Widhalm G; Preusser M; Berghoff AS
    Cancer; 2020 Oct; 126(19):4341-4352. PubMed ID: 32678971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic sites and survival in lung cancer.
    Riihimäki M; Hemminki A; Fallah M; Thomsen H; Sundquist K; Sundquist J; Hemminki K
    Lung Cancer; 2014 Oct; 86(1):78-84. PubMed ID: 25130083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study.
    Tawbi H; To TM; Bartley K; Sadetsky N; Burton E; Haydu L; McKenna E
    Cancer Med; 2022 Jan; 11(1):139-150. PubMed ID: 34874127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial Metastatic Disease: Present Challenges, Future Opportunities.
    Li AY; Gaebe K; Jerzak KJ; Cheema PK; Sahgal A; Das S
    Front Oncol; 2022; 12():855182. PubMed ID: 35330715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients.
    Lauten M; Attarbaschi A; Cario G; Döring M; Moser O; Mücke U; Poyer F; Rieken S; Temme C; Voigt S; Lehrnbecher T; Groll AH
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27806. PubMed ID: 31066209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
    Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
    J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
    Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
    Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.
    Skarsgard DP; Groome PA; Mackillop WJ; Zhou S; Rothwell D; Dixon PF; O'Sullivan B; Hall SF; Holowaty EJ
    Cancer; 2000 Apr; 88(7):1728-38. PubMed ID: 10738233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastases.
    Dutta SW; Mack ML; Aliotta E; Ward KA; Muller DA; Larner JM; Fadul CE; Hall RD; Gentzler RD; Sheehan JP
    J Neurooncol; 2020 Sep; 149(2):357-366. PubMed ID: 32902767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.